Fidelis Capital Partners’s Colgate-Palmolive CL Stock Holding History

Fidelis Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Sell	3,882 -569	-13%	-$49.8K	0.02%	401
2026 Q1	$379K	Buy	4,451 +226	+5%	+$20.1K	0.03%	361
2025 Q4	$334K	Sell	4,225 -1,441	-25%	-$113K	0.02%	380
2025 Q3	$453K	Sell	5,666 -8,909	-61%	-$760K	0.04%	326
2025 Q2	$1.23M	Buy	14,575 +550	+4%	+$50.2K	0.11%	150
2025 Q1	$1.32M	Sell	14,025 -1,146	-8%	-$103K	0.14%	120
2024 Q4	$1.32M	Buy	15,171 +1,359	+10%	+$130K	0.13%	134
2024 Q3	$1.37M	Buy	13,812 +1,173	+9%	+$120K	0.16%	116
2024 Q2	$1.29M	Buy	12,639 +5,175	+69%	+$477K	0.18%	95
2024 Q1	$672K	Buy	7,464 +3,898	+109%	+$330K	0.1%	178
2023 Q4	$284K	Buy	+3,566	New	+$268K	0.06%	257

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelis Capital Partners's CL Position: Q2 2026 in Review

Fidelis Capital Partners reduced its Colgate-Palmolive (CL) stake by 13% in Q2 2026, selling an estimated $49.8K and leaving 3,882 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #401.

Fidelis Capital Partners first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Fidelis Capital Partners held 3,882 shares of Colgate-Palmolive worth $356K as of Q2 2026.
Fidelis Capital Partners sold 569 Colgate-Palmolive shares in Q2 2026, an estimated $49.8K.
Colgate-Palmolive made up 0.02% of Fidelis Capital Partners's portfolio in Q2 2026, its #401 holding.
Fidelis Capital Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
Fidelis Capital Partners's Colgate-Palmolive position peaked at $1.37M in Q3 2024.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.